Alzheimer-kór: vizsgálatok itt: Kolumbia
3 of 4 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease
- Where
- Medellín
- Életkor
- 25 év to 65 év
- People
- 240
- Run by
- Banner Health
See details and how to joinNCT06996730 - 2/3. fázisTaking peopleA Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Where
- Medellín
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Washington University School of Medicine
See details and how to joinNCT05552157 - 2/3. fázisTaking peopleA Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Where
- Medellín
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Washington University School of Medicine
See details and how to joinNCT06647498